First-line treatment of adult subjects with high-risk large B-cell lymphoma (LBCL) including diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS) and high-grade B-cell lymphoma (HGBL).

• Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell L … Recruiting
  2022-501489-24-00 5 2025-03-28

Showing 1–1 of 1 trials